Related references
Note: Only part of the references are listed.Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenstrom's Macroglobulinemia complicated by Bing-Neel syndrome
Marzia Varettoni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Bing-Neel syndrome, a rare complication of Waldenstrom macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)
Laurence Simon et al.
HAEMATOLOGICA (2015)
Bing-Neel syndrome, a rare complication of Waldenstrom macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)
Laurence Simon et al.
HAEMATOLOGICA (2015)
Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database
Jorge J. Castillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Survival trends in Waldenstrom macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database
Jorge J. Castillo et al.
BLOOD (2014)
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome
Stephanie Poulain et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series
Marc C. Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2014)
Detection of MYD88 L265P in peripheral blood of patients with Waldenstrom's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
L. Xu et al.
LEUKEMIA (2014)
Successful Treatment of Bing-Neel Syndrome Using Intrathecal Chemotherapy and Systemic Combination Chemotherapy Followed by BEAM Auto-Transplant: A Case Report and Review of Literature
Al-Ola Abdallah et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
Lakshmi Nayak et al.
LEUKEMIA & LYMPHOMA (2013)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
RITUXIMAB MONOTHERAPY FOR PATIENTS WITH RECURRENT PRIMARY CNS LYMPHOMA
T. T. Batchelor et al.
NEUROLOGY (2011)
Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature
Roneil G. Malkani et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
Marc C. Chamberlain et al.
NEURO-ONCOLOGY (2010)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
Bendamustine: Rebirth of an Old Drug
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bing-Neel Syndrome: A Case Report and Systematic Review of Clinical Manifestations, Diagnosis, and Treatment Options
Jaspreet S. Grewal et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Bing-Neel Syndrome Revisited
Florian Fintelmann et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia
S Knop et al.
LEUKEMIA & LYMPHOMA (2005)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)